These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17331531)

  • 1. Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.
    Millo E; Pietra G; Armirotti A; Vacca P; Mingari MC; Moretta L; Damonte G
    J Immunol Methods; 2007 Apr; 322(1-2):128-36. PubMed ID: 17331531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
    Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
    J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry.
    Woods AS; Huang AY; Cotter RJ; Pasternack GR; Pardoll DM; Jaffee EM
    Anal Biochem; 1995 Mar; 226(1):15-25. PubMed ID: 7785766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced sensitivity for sequence determination of major histocompatibility complex class I peptides by membrane preconcentration-capillary electrophoresis-microspray-tandem mass spectrometry.
    Naylor S; Ji Q; Johnson KL; Tomlinson AJ; Kieper WC; Jameson SC
    Electrophoresis; 1998 Sep; 19(12):2207-12. PubMed ID: 9761205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC and MS analysis for the identification and characterisation of peptides presented in the context of the non-classical human leukocytes antigen (HLA) class I molecule HLA-E.
    Millo E; Damonte G
    Curr Pharm Des; 2009; 15(28):3325-35. PubMed ID: 19860682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HLA-DRB1-bound self-peptides following measles virus infection.
    Ovsyannikova IG; Johnson KL; Naylor S; Poland GA
    J Immunol Methods; 2005 Feb; 297(1-2):153-67. PubMed ID: 15777939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays.
    Brockman AH; Orlando R; Tarleton RL
    Rapid Commun Mass Spectrom; 1999; 13(11):1024-30. PubMed ID: 10368978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
    Antwi K; Hanavan PD; Myers CE; Ruiz YW; Thompson EJ; Lake DF
    Mol Immunol; 2009 Sep; 46(15):2931-7. PubMed ID: 19615748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of class II HLA-DRB1*03-bound measles virus peptides by 2D-liquid chromatography tandem mass spectrometry.
    Johnson KL; Ovsyannikova IG; Poland GA; Muddiman DC
    J Proteome Res; 2005; 4(6):2243-9. PubMed ID: 16335972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding.
    Engelhard VH; Appella E; Benjamin DC; Bodnar WM; Cox AL; Chen Y; Henderson RA; Huczko EL; Michel H; Sakaguichi K
    Chem Immunol; 1993; 57():39-62. PubMed ID: 8260089
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.
    Huczko EL; Bodnar WM; Benjamin D; Sakaguchi K; Zhu NZ; Shabanowitz J; Henderson RA; Appella E; Hunt DF; Engelhard VH
    J Immunol; 1993 Sep; 151(5):2572-87. PubMed ID: 8360479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
    Torabi-Pour N; Nouri AM; Perrett D; Oliver RT
    Biomed Chromatogr; 2001 Feb; 15(1):18-24. PubMed ID: 11180296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.
    Lemmel C; Weik S; Eberle U; Dengjel J; Kratt T; Becker HD; Rammensee HG; Stevanovic S
    Nat Biotechnol; 2004 Apr; 22(4):450-4. PubMed ID: 15004565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of self peptides bound to purified HLA-B27.
    Jardetzky TS; Lane WS; Robinson RA; Madden DR; Wiley DC
    Nature; 1991 Sep; 353(6342):326-9. PubMed ID: 1922338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide mapping with mobile phases of intermediate pH value using capillary reversed-phase high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Yang Y; Boysen RI; Harris SJ; Hearn MT
    J Chromatogr A; 2009 May; 1216(18):3767-73. PubMed ID: 19285675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of a naturally presented MAGE-A3 epitope on the surface of HLE cell line by mass spectrometry].
    Peng JR; Dong N; Liu HW; Leng XS
    Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):595-7. PubMed ID: 17688791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry and peptide-based vaccine development.
    Ovsyannikova IG; Johnson KL; Bergen HR; Poland GA
    Clin Pharmacol Ther; 2007 Dec; 82(6):644-52. PubMed ID: 17971823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
    Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
    Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
    Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
    Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.